Evidence map›Paper›PMID 39082807›Full record

ArticleApplied and environmental microbiology2024

Mapping the functional B-cell epitopes of

Siqi Li, Weiping Zhang

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Applied and environmental microbiology · 2026
    Article
  2. Review
  3. Recent progress in enterotoxigenicInfection and immunity · 2025
    Review
  4. Article
  5. Characterization ofApplied and environmental microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Siqi LiDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Weiping ZhangDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0002-3723-2257

Funding

A cross protective multivalent vaccine for Shigella and ETECR01AI175214 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DAVID A SACK · 2023 to 2026
$3.0M
NIAID NIH HHS R01 AI175214
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, BacterialEpitopes, B-LymphocyteShigella flexneriAnimalsAntibodies, BacterialBacterial ProteinsDysentery, BacillaryEpitope MappingFemaleMiceMice, Inbred BALB CShigellaShigella sonneiShigella VaccinesType III Secretion SystemsAntibodies, BacterialAntigens, BacterialBacterial ProteinsEpitopes, B-LymphocyteIpaD protein, Shigella flexneriShigella VaccinesType III Secretion Systemsepitope mappinginvasion plasmid antigenIpaDShigella spp.type III secretion system (T3SS)vaccine

Identifiers

PMID39082807
PMCPMC11337796

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.